Fibrinogen-to-red blood cell ratio is associated with disease burden and short-term outcomes in hospitalized patients with gout: comparison with conventional inflammatory indices - Report - MDSpire

Fibrinogen-to-red blood cell ratio is associated with disease burden and short-term outcomes in hospitalized patients with gout: comparison with conventional inflammatory indices

  • By

  • Hao-Jie Zhong

  • Shu-Juan Chen

  • Xiao-Lan Qian

  • Min Xiao

  • Gui-Chen Ling

  • Jian-Yong Zhang

  • Jing-Jing Xie

  • July 15, 2026

Share

Association of Fibrinogen-to-Red Blood Cell Ratio with Disease Severity in Gout

Overview

This study evaluates the fibrinogen-to-red blood cell ratio (FRR) in hospitalized gout patients, revealing its association with disease severity, inflammatory markers, and short-term outcomes. FRR demonstrated stronger correlations with traditional inflammatory markers compared to the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.

Background

Gout is a prevalent chronic inflammatory arthritis that can lead to significant morbidity if not managed effectively. Traditional inflammatory markers have limitations in fully capturing the disease burden and inflammatory status in gout patients. The exploration of FRR as a potential biomarker may enhance the understanding of gout's inflammatory profile.

Data Highlights

ParameterHigh FRRLow FRR
Annual flaresMore frequentLess frequent
Prevalence of tophiHigherLower
CRP levelsHigherLower
30-day readmission ratesHigherLower

Key Findings

  • High FRR is associated with more frequent annual flares in gout patients.
  • Patients with high FRR have a higher prevalence of tophi and affected joints.
  • FRR correlates more strongly with CRP and ESR compared to NLR and PLR.
  • High FRR is independently associated with proteinuria and 30-day readmission rates.
  • FRR shows higher AUCs than NLR and PLR for predicting tophi and proteinuria.

Clinical Implications

The findings indicate that FRR is associated with disease burden and inflammatory activity in gout patients.

Conclusion

FRR is associated with disease severity and short-term outcomes in hospitalized gout patients.

Related Resources & Content

  1. Clinical Rheumatology, 2022 -- The Relationship Between Coagulation and Gout Disease Activity
  2. Frontiers in Medicine, 2026 -- Associations of systemic immune-inflammation index and aggregate index of systemic inflammation with acute gouty arthritis in men
  3. Frontiers in Endocrinology, 2026 -- Association of the serum uric acid to high-density lipoprotein cholesterol ratio with in-hospital mortality in patients with acute kidney injury
  4. 2020 American College of Rheumatology Guideline for the Management of Gout - PMC
  5. Frontiers in Neurology — Association between uric acid to lymphocyte ratio and poor functional outcomes in acute ischemic stroke patients
  6. 2020 American College of Rheumatology Guideline for the Management of Gout - PMC
  7. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout | New England Journal of Medicine
  8. Analysis of Superb Microvascular Imaging Blood Flow Scoring, Disease Duration, and Laboratory Indicators Involved in Gout - PubMed

Original Source(s)

Related Content